🇺🇸 FDA
Patent

US 11918646

Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration

granted A61KA61K2039/543A61K2039/55505

Quick answer

US patent 11918646 (Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration) held by The Board of Regents of the University of Texas System expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/543, A61K2039/55505, A61K39/02, A61K39/12